What is Arexvy? US approves first vaccine for RSV after decades of attempts
The US has approved the first vaccine for respiratory syncytial virus (RSV) for people aged 60 and over. On Wednesday the Food and Drug Administration (FDA) approved the use of Arexvy in…
